Child LIMPRINT

Background

Child LIMPRINT is the first national prevalence study to determine the number of children and young people. This study is supported by an international panel of experts and has been awarded a major grant of 4,6 million DKK by the ELLAB-Foundation in 2021 to run over the next five years. 

Initial funding was provided by ILF to design the project and to enable us to seek grant funding. 

Project Summary

Aim

To estimate the national prevalence and impact of lymphoedema in children and young adults (aged up to 30 years) within the Danish population, using a staged approach and mixed methods.

Objectives

Study Setting

National study coordinated by the Copenhagen Wound Healing and lymphoedema Centre at Bispebjerg Hospital, Denmark

Progress to Date

The study has full ethical approval (project H-19083222 ) and has recruited 84 children since its inception.

Screening of the data registry commenced, and a random sample has been identified to be included in the study. All those included will be prospectively followed up at 6 monthly intervals throughout the project and clinical, cost and quality of life data (EQ5D and disease specific tools) captured.

SUPPORTED BY

Ellab-Fonden logo

PRESS RELEASE

Lymphedema clinic receives a million grant to help children and young people with lymphoedema

PRESS RELEASE

Lymphedema clinic receives a million grant to help children and young people with lymphoedema
READ IT

PRESS RELEASE

Helping children and young people with lymphoedema

PRESS RELEASE

Helping children and young people with lymphoedema
READ
Bispebjerg Hospital

Child Limprint is coordinated by the Copenhagen Wound Healing and Lymphoedema Centre at Bispebjerg Hospital, Denmark